Imfinzi combination fails advanced lung cancer study - European Pharmaceutical Review

Imfinzi combination fails advanced lung cancer study  European Pharmaceutical Review

A late-stage clinical trial for Imfinzi and an experimental treatment has not extended the lives of patients with advanced non-small cell lung cancer.